Healthcare Triangle Inc. Common Stock (HCTI)

FairStock Score: 45/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Mr. Market is offering this at $0.42 as of 2026-10-13, down from a 52-week high of $188.40, and the allure is obvious: FairStock's price-to-book is 0.04 and market cap is only $6.3M. Graham would ask whether the assets are real and earning power is intact. Here, the earnings record says no. The company lost money in each of the last four years, so FairStock assigns no Peter Lynch category. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $9.2M but net income was -$4.4M. A year earlier, fiscal Q2 2025, revenue was $3.6M and net income was -$1.4M. Top-line growth is impressive-up more than 150%-but the loss widened, and latest quarter margin was -47.72%. In fiscal year 2025, revenue was $13.9M and net income -$9.5M; in fiscal year 2024, revenue $11.7M and net income -$6.0M. This is not a business compounding owner earnings. It is a business consuming them. TTM free cash flow is -$17.6M, a FCF yield of -280.9% against the tiny market cap, so the cash burn exceeds the entire equity value. The balance sheet has D/E of 0.26, not terrifying, but FairStock's Altman Z-score of -1.02 signals distress, its Piotroski score is 3/9, and ROE is -57.40%. Revenue growth without profit is a mirage if each sale costs more than it brings. A low P/B can be a trap when losses erode book value. I see no durable moat in a 40-person IT services firm. Without evidence of positive cash flow, this is speculation, not value.

In plain English: Healthcare Triangle is a small healthcare technology company that helps hospitals and life-science groups with cloud, data, and electronic health record services. It has been losing money and burning cash, even though revenue jumped in the most recent quarter. The stock price is very low compared with the company's stated assets minus debts, but the losses make that cheapness look risky rather than attractive.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K/A (period ended 2025-12-31) · FY2024 10-K/A (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer